XML 55 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-based compensation (Tables)
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
The weighted-average assumptions used in the option valuation model and the resulting weighted-average grant date fair values of stock options granted were as follows:
 
Years ended December 31,
 
2017
 
2016
Closing price of our common stock on grant date
$
162.60

 
$
156.35

Expected volatility (average of implied and historical volatility)
22.7
%
 
24.3
%
Expected life (in years)
5.8

 
5.8

Risk-free interest rate
2.1
%
 
1.5
%
Expected dividend yield
2.8
%
 
2.6
%
Fair value of stock options granted
$
27.54

 
$
27.55

Components of stock-based compensation expense recognized in the Consolidated Statements of Income
The following table reflects the components of stock-based compensation expense recognized in our Consolidated Statements of Income (in millions):
 
Years ended December 31,
 
2017
 
2016
 
2015
RSUs
$
174

 
$
177

 
$
190

Performance units
133

 
123

 
132

Stock options
22

 
11

 

Total stock-based compensation expense, pretax
329

 
311

 
322

Tax benefit from stock-based compensation expense
(118
)
 
(112
)
 
(120
)
Total stock-based compensation expense, net of tax
$
211

 
$
199

 
$
202

Summary of RSUs
The following table summarizes information regarding our RSUs:
 
Year ended December 31, 2017
 
Units
(in millions)
 
Weighted-average
grant date
fair value
Balance nonvested at December 31, 2016
3.9

 
$
141.07

Granted
1.3

 
$
163.99

Vested
(1.5
)
 
$
125.32

Forfeited
(0.3
)
 
$
149.79

Balance nonvested at December 31, 2017
3.4

 
$
155.11

Weighted average assumptions used and the resulting weighted average grant date fair value of performance units
The weighted-average assumptions used in this model and the resulting weighted-average grant date fair values of performance units granted were as follows:
 
Years ended December 31,
 
2017
 
2016
 
2015
Closing price of our common stock on grant date
$
162.60

 
$
156.35

 
$
164.26

Volatility
25.9
%
 
25.8
%
 
24.3
%
Risk-free interest rate
1.4
%
 
0.9
%
 
0.8
%
Fair value of units granted
$
178.87

 
$
170.56

 
$
182.55

Summary of stock options
The following table summarizes information regarding our stock options:
 
Year ended December 31, 2017
 
Options
(in millions)
 
Weighted-
average
exercise price
 
Weighted-
average
remaining
contractual
life (in years)
 
Aggregate
intrinsic
value
(in millions)
Balance unexercised at December 31, 2016
3.1

 
$
100.21

 
 
 
 
Granted
1.5

 
$
162.60

 
 
 
 
Exercised
(0.5
)
 
$
57.24

 
 
 
 
Expired/forfeited
(0.1
)
 
$
159.13

 
 
 
 
Balance unexercised at December 31, 2017
4.0

 
$
127.08

 
6.9
 
$
186

Vested or expected to vest at December 31, 2017
3.7

 
$
124.84

 
6.8
 
$
182

Exercisable at December 31, 2017
1.3

 
$
58.23

 
2.8
 
$
147